Highly conserved TREX-mediated mRNA export is emerging as a key pathway in neuronal development and differentiation. TREX subunit variants cause neurodevelopmental disorders (NDDs) by interfering with mRNA export from the cell nucleus to the cytoplasm. Previously we implicated four missense variants in the X-linked THOC2 gene in intellectual disability (ID). We now report an additional six affected individuals from five unrelated families with two de novo and three maternally inherited pathogenic or likely pathogenic variants in THOC2 extending the genotypic and phenotypic spectrum. These comprise three rare missense THOC2 variants that affect evolutionarily conserved amino acid residues and reduce protein stability and two with canonical splice-site THOC2 variants that result in C-terminally truncated THOC2 proteins. We present detailed clinical assessment and functional studies on a de novo variant in a female with an epileptic encephalopathy and discuss an additional four families with rare variants in THOC2 with supportive evidence for pathogenicity. Severe neurocognitive features, including movement and seizure disorders, were observed in this cohort. Taken together our data show that even subtle alterations to the canonical molecular pathways such as mRNA export, otherwise essential for cellular life, can be compatible with life, but lead to NDDs in humans.
INTRODUCTION
Intellectual disability (ID), characterized by substantial limitations in both intellectual functioning and adaptive behavior, affects 1%-3% of the population starting before the age of 18 years and has significant impact on individuals, families, and communities (Vissers, Gilissen, & Veltman, 2016) . Individuals with ID are more likely than members of the general population to experience poor physical and mental health, have a lower life expectancy, experience inequalities accessing health care, and frequently have limited or no specific therapies for their core symptoms (Bittles et al., 2002; Hosking et al., 2016) . Both genetic and environmental factors contribute to the development of ID (Milani, Ronzoni, & Esposito, 2015) . Over 120 of the identified >800 ID genes are located on the X-chromosome (Chiurazzi & Pirozzi, 2016; Schwartz, 2015) , and diagnosis of X-linked causes of ID remain critically important for accurate genetic counseling of families (Ropers & Hamel, 2005) . Dramatic improvements in high-throughput DNA sequencing technologies and analyses software has led to identification of new ID genes and additional variants in the known ID genes (Dickinson et al., 2016; Vissers, et al., 2016) . A systematic review of clinical data suggests that ID affected individuals frequently have comorbid neurological, psychiatric, and behavioral disorders (Oeseburg, Dijkstra, Groothoff, Reijneveld, & Jansen, 2011; Vissers et al., 2016) , and disease variants in different parts of a gene can lead to a broad range of complex neurocognitive disorders (Palmer et al., 2017; Zhu, Need, Petrovski, & Goldstein, 2014) . This complexity contributes to heterogeneity in clinical symptoms and indistinct boundaries between syndromic and nonsyndromic forms of neurodevelopmental disorder (NDD).
In 2015, we reported genetic, molecular, and protein structural data on four missense variants in an X-linked essential gene THOC2 (MIM# 300957; NM_001081550.1; c.937C>T (p.Leu313Phe), c.1313T>C (p.Leu438Pro), c.2399T>C (p.Ile800Thr), and c.3034T>C (p.Ser1012Pro), RNA not analyzed) (Kumar et al., 2015) . The affected individuals had a syndromic NDD, characterized by borderline to severe ID, speech delay, short stature, and adult onset truncal obesity (Kumar et al., 2015) . THOC2 encodes for the THOC2 proteinthe largest subunit of the highly conserved TREX (TranscriptionExport) mRNA export complex essential for exporting mRNA from the cell nucleus to the cytoplasm (Heath, Viphakone, & Wilson, 2016) .
The TREX complex is composed of a THO sub-complex (THOC1, THOC2, THOC3, THOC5, THOC6, and THOC7) and accessory proteins (UAP56, UIF, Aly, CIP29, PDIP3, ZC11A, SRRT, Chtop) (Heath et al., 2016) . The TREX complex, besides its canonical role in mRNA export in the mammalian cells, has been shown to play critical roles in gene expression, 3 ′ mRNA processing, stress responses, mitotic progression, and genome stability as well as developmental processes such as pluripotency maintenance and hematopoiesis (Yamazaki et al., 2010) . We and others have recently demonstrated that subtle perturbations in mRNA export by gene variants or preferential cytoplasmic aggregation can lead to NDDs (Beaulieu et al., 2013; Coe et al., 2014; Kumar et al., 2015) , neurodegeneration (Woerner et al., 2016) , or cancer (Chinnam et al., 2014; Hautbergue, 2017; Liu et al., 2015; Viphakone et al., 2015) . These alterations can have tissue-specific effects as TREX subunits are shown to have tissue-specific roles; for example, mouse Thoc5 and Thoc1 deficiency interferes with the maintenance of hematopoiesis (Guria et al., 2011; Mancini et al., 2010) and testis development (Wang et al., 2009) . Taken together, altered TREX function can have diverse molecular and cellular consequences resulting in a range of diseases. Here, we present detailed information on the clinical presentations and functional investigations on an additional eight missense and two splice THOC2 variants. These data reaffirm and extend our previous findings that THOC2 variation plays a role in complex neurodevelopmental conditions with the core clinical presentation of ID.
MATERIALS AND METHODS

Molecular and cellular studies
RNA extraction, RT-qPCR (primers listed in Supp. Table S3 ), cycloheximide chase, and THOC2 immunofluorescence staining were performed as reported previously (Kumar et al., 2015) . Molecular studies on the THOC2 exon35:c.4450-2A>G variant were performed using blood DNA and skin fibroblasts derived from the affected individual and his heterozygous carrier mother. Genomic DNA or cDNA (generated by reverse transcribing the fibroblast total RNAs using Superscript III reverse transcriptase; Life Technologies, Scoresby, Victoria, Australia) was amplified with KAPA HiFi PCR Kit (Kapa Biosystems, Mulgrave, Victoria, Australia) using hTHOC2-4326F/hTHOC2-4519-R (Supp . Table S3) 
Generation of THOC2 variant expression constructs
Generation of the wild-type Myc-tagged human THOC2 expression plasmid was reported earlier (Kumar et al., 2015) . Briefly, the THOC2 variants were introduced into the existing pCMV-Myc-THOC2 expression construct by overlap PCR method using the primers listed in Supp. 
Transient expression and Western blotting
For transient expression experiments, HEK293T and HeLa cells were transfected with expression constructs (400 ng pCMV-Myc-THOC2 plasmid and 400 ng pEGFP-C1 plasmid/transfection for stability and cycloheximide assays and 4 g/transfection for immunofluorescence staining, IF) using Lipofectamine 3000 reagent according to manufacturer's protocol (Life Technologies). Twenty-four hours posttransfection, cells were either fixed with 4% formaldehyde for IF or collected and lysed in buffer containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% Triton-X 100, 1 mM EDTA, 50 mM NaF, 1× Protease inhibitor/no EDTA and 0.1 mM Na 3 VO 4 for Western blot assay as reported previously (Kumar et al., 2015) .
In silico pathogenicity prediction
We used CADD v1.3 (includes Phylop, GERP++ & PolyPhen2) (Kircher et al., 2014) , Provean (Choi & Chan, 2015) , and ACMG (Richards et al., 2015) on-line tools for in silico prediction of the pathogenicity of different variants (Table 1 and Supp. Table S1 ).
RESULTS
Identification of THOC2 variants
We previously implicated four missense THOC2 variants in 25 individuals with ID and a range of other clinical features (Table 1 and Supp. Table S1 and 2) (Kumar et al., 2015) . We identified an additional five 
Clinical presentations
The clinical features of the five previously unreported affected individuals with (likely) pathogenic THOC2 variants, aged between 3 and 12 years, and the 10 year old female with de novo p.Tyr517Cys variant are summarized in Table 2 and photographs, when available, are shown in (Kim et al., 2011) and K345 (Lopitz-Otsoa et al., 2012; Wagner et al., 2011) ), phosphorylated (S1448 and 1486 (Olsen et al., 2006) ) amino acid residues, potential RNA binding domain (RBD) and destruction box (D-box) and KEN box sequences that interact with the Anaphase Promoting Complex/Cyclosome (APC/C) for protein ubiquitination and subsequent destruction by the proteasome (Morgan, 2013) are shown. Unreported (orange) and published (black: (Kumar et al., 2015) ) missense variants effecting THOC2 protein stability are marked with red lollipops. The positions of two splice variants are shown in red 
THOC2 variant protein localization and stability
Without access to affected individuals' derived cells, we generated Myc-tagged THOC2 missense variant expression constructs to determine protein stability and localization. The THOC2 protein stability was determined in HEK293T cells and localization in both the HEK293T and HeLa cells. Total protein lysates of HEK293T cells ectopically-expressing the wild-type or variant Myc-THOC2 proteins were Western blotted for THOC2, EGFP, and -Tubulin. We used HEK293T cells expressing Myc-p.Ile800Thr THOC2 as a control for F I G U R E 3 Functional testing of THOC2 missense variants. A: THOC2 variant protein stability is reduced in HEK293T cells. pCMVMyc-THOC2 wild-type or variant expression constructs and pEGFP-C1 plasmid (transfection control) were transfected into HEK293T cells. Total protein lysates of cells 24 hr post-transfection were analyzed by Western blotting with mouse anti-Myc (clone 9E10; Sigma), mouse anti-EGFP (clones 7.1 and 13.1; Roche) and rabbit anti--tubulin (loading control; Abcam) antibodies. pCMV-Myc-THOC2 p.Ile800Thr construct expressing the p.Ile800Thr protein shown to have reduced stability was used as a control (Kumar et al., 2015) . Western blot signals were quantified using ImageJ software. Averages of the Myc-THOC2 proteins normalized to the housekeeping -tubulin signal from two independent runs are shown. B: Myc-p.Tyr517Cys THOC2 protein half-life is substantially reduced in HEK293T cells. pCMV-Myc-THOC2 or pCMV-Myc-THOC2-p.Tyr517Cys expression constructs and pEGFP-C1 plasmid (transfection control) were transfected into HEK293T cells. Next day the cells were cultured in the presence of 100 g/ml translation inhibitor cycloheximide and harvested at the time points shown. Total protein lysates were analyzed by Western blotting with mouse anti-Myc, mouse anti-EGFP, and rabbit anti--tubulin (loading control) antibodies protein stability assay as this variant is shown to cause reduced protein stability (Kumar et al., 2015) . The results showed reduced stability of p.Tyr517Cys, p.Thr696Ile, p.Gly713Asp, and p.His1187Tyr THOC2 compared with the wild-type protein ( Figure 3A) . Presence of comparable levels of EGFP in the cells transfected with different expression constructs indicated that the reduced levels of THOC2 protein were not due to difference in transfection efficiency ( Figure 3A ).
We also determined the turnover rate of Myc-p.Tyr517Cys THOC2 protein by cycloheximide chase. For this assay, the HEK293T cells transfected with pCMV-Myc-WT or pCMV-Myc-p.Tyr517Cys THOC2 and pEGFP-C1 transfection control plasmids were cultured in presence of translation inhibitor cycloheximide for different durations and Western blotted for THOC2, EGFP, and -Tubulin. The results showed that p.Tyr517Cys THOC2 turnover rate was 3 hr compared with 8 hr for the wild-type protein ( Figure 3B ). THOC2 variant proteins, similar to the wild-type, were mainly localized to the nucleus in both the HEK293T and HeLa cells (Supp. Figure S3 ). 
THOC2
E 2 Summary of clinical data of THOC2 variants with supporting molecular evidence (Likely)
DISCUSSION
Here, we present detailed clinical information, and molecular and functional studies, on five previously unreported THOC2 variants in six affected males (two de novo variants and one maternally inherited variant in monozygotic twins) and on one affected female with a previously reported de novo p.Tyr517Cys variant. We present evidence that extends the genotypic spectrum beyond the four THOC2 missense variants that we reported previously (Kumar et al., 2015) by including two intronic variants that affect splicing, and four missense variants that affect protein stability in a cell-based assay system. According to ACMG criteria, they were classified as pathogenic or likely pathogenic (Table 1) (Richards et al., 2015) . These findings, along with the four missense variants reported earlier (Kumar et al., 2015) , add to the existing evidence that alterations in essential mRNA export pathway cause NDDs (Amos et al., 2017; Beaulieu et al., 2013; Kumar et al., 2015) .
We confirm that the core clinical feature of THOC2-related disorder in hemizygous males is ID, with several individuals having additional features including behavioral disorders, hypotonia, gait disturbance, tremor, low birth weight, short stature, microcephaly, and variable neuroimaging findings. Although the range of neurodevelopmental features is similar, our original cohort contained males with ID in the mild or borderline range of intellectual functioning (Kumar et al., 2015) , whereas all individuals in this cohort have ID which is at least in the moderate range. Individuals 2 and 6 had neurological signs that could be consistent with cerebellar dysfunction including tremor and a broad-based gait for individual 2 and nystagmus, tremor, and an ataxic broad-based gait for individual 6, in the absence of significant cerebellar abnormalities on MRI. This is interesting given the female patient with knockdown of THOC2 function due to a de novo X;8 translocation that created a PTK2-THOC2 fusion had congenital cerebellar hypoplasia and prominent cerebellar signs with mild ID (Di Gregorio et al., 2013) . We used computerized face-matching technology to specifically evaluate the cohort to assess if a characteristic facial gestalt was evident across individuals with pathogenic or likely pathogenic variants across our original and this expanded clinical cohort (Supp. Figure S4 ) (Dudding-Byth et al., 2017) . Although a clearly recognizable facial gestalt was not obvious, there are some similarities. The facial gestalt spectrum associated with THOC2 pathogenic variants will continue to emerge as more individuals are reported.
As was the case in our original cohort, heterozygous mothers were clinically unaffected, and, where available, X-chromosome inactivation (XCI) was highly skewed (Table 1) . In contrast individual 7, with a de novo missense variant (p.Tyr517Cys) is a female with a particularly severe neurocognitive presentation. This is consistent with other reported severely affected females with de novo variants in X linked genes (de Lange et al., 2016; Palmer et al., 2016; Snijders Blok et al., 2015; Zweier et al., 2014) . Unfortunately, we did not have access to individual 7 ′ s genomic DNA to test XCI status.
A range of protein-protein interactions are required for mRNA export (Chi et al., 2013) . Proteins with altered stability (Hirayama et al., 2008) , localization (Beaulieu et al., 2013 ) (e.g., THOC6 p.Gly46Arg implicated in syndromic ID), or interaction (Chi et al., 2013) (Chi et al., 2013; Kumar et al., 2015) . Reduced levels of THOC2 missense variant proteins are most likely due to enhanced proteasome-mediated degradation as THOC2 is ubiquitinated (LopitzOtsoa et al., 2012) . THOC2 depletion has been reported to have different consequences in diverse organisms. For example, shRNA-mediated Thoc2 knockdown leads to significant increase in length of neurites in cultured rat primary hippocampal neurons (Di Gregorio et al., 2013) although effects on neurons with persistently reduced THOC2 variant proteins in the affected individuals may be different and Caenorhabditis elegans thoc2 knockouts, that are completely immobile, slow-growing, sterile, have functional defects in specific sensory neurons and die prematurely (Di Gregorio et al., 2013) . Danio rerio Thoc2 is essential for embryonic development (Amsterdam et al., 2004) and in Drosophila melanogaster S2 cells Thoc2 knockdown inhibits mRNA export and cell proliferation (Rehwinkel et al., 2004) . THOC2 depletion also results in chromosome alignment, mitotic progression, and genomic stability in human HeLa cells (Yamazaki et al., 2010) . Finally, Thoc2 and Thoc5 knockdown experiments have shown their role in regulation of embryonic stem cell (ESC) self-renewal . Indeed reduced THOC2 levels are shown to destabilize the TREX complex in humans (Chi et al., 2013; Kumar et al., 2015) and removal of any THO subunit causes destabilization of other TREX components in yeast (Pena et al., 2012) .
Systematic functional analysis of the Tho2 C-terminal RNA binding region in yeast provides interesting explanation as to how the truncated THOC2 protein can perturb normal mRNA export function in human cells (Pena et al., 2012) (Figure 6 ). The data showed that whereas ∆Tho2 yeast strain does not grow at 37 • C (restrictive temperature), Tho2∆ 1,408-1,597 and Tho∆ 1,271-1.597 growth is considerably reduced, suggesting that C-terminal 1,271-1,597 amino acids are required for cell survival at restrictive temperature (Pena et al., 2012 (Lek et al., 2016) , affect highly evolutionarily conserved amino acid residues, are predicted to be pathogenic by in silico analyses and are within the clinical presentations spectrum of those seen in individuals with confirmed THOC2-related ID. However, they lack supportive evidence from our existing functional assays. These variants may still have a detrimental effect on THOC2 function due to altered protein structure impacting protein-RNA and/or protein-protein interactions with known or unknown TREX subunits [e.g., Boehringer et al., 2017] . The challenge of proving causality for previously unreported missense variants in NDD genes is well recognized and speaks to the need for ongoing intertwined clinical and research efforts to clarify causality of VOUS (Wright et al., 2018) .
We therefore report detailed variant and clinical data (see Supp. materials, Supp. Table S1 and S2, and Supp. Figure S4 ) with the intention of alerting researchers and clinicians to these variants, as future studies, THOC2 is ubiquitously expressed in all human tissues (Thul et al., 2017) and more specifically in the developing and mature human brain (Johnson et al., 2009; Kumar et al., 2015; Uhlen et al., 2015) and mouse brain, with higher abundance in frontal cortex and cerebellum (Di Gregorio et al., 2013; Kumar et al., 2015) . THOC2 is an essential mRNA export factor as its siRNA-mediated depletion results in almost complete retention of mRNAs in the cell nucleus (Chi et al., 2013) , potentially toxic to the cell. These data are consistent with the findings that THOC2 is a highly constrained gene (Samocha et al., 2014) F I G U R E 6 Summary of truncated human THOC2 proteins translated from aberrantly spliced mRNAs and functional outcomes of yeast C-terminal Tho2 deletion strains (Pena et al., 2012) . Blue boxes depict the 52 and 7 amino acids coded by unspliced intron sequences of exon35:c.4550-2T>C and exon28:c.3503+4A>C variants, respectively. WT, +++ = normal, ∆1,408-1,597aa, ++ and ∆1,271-1,597aa = reduced growth at restrictive temperature and THOC (e.g., THOC1, 3, 5, 6 , and 7) genes are essential for cell survival (Blomen et al., 2015) . Taken together, as THOC2 knockout cells will not survive due to complete mRNA nuclear retention, we predict that the identified THOC2 variants represent partial loss-of-function that disrupt normal mRNA export in neuronal and possibly other cell types, potentially causing variable clinical presentations.
TREX complex couples transcription and mRNA biogenesis with nuclear mRNA export, and has emerged as an essential pathway in embryogenesis, organogenesis and differentiation (Heath et al., 2016) .
For example, Thoc2 and Thoc5 selectively bind and regulate export of mRNAs (e.g., Nanog, Sox2, Esrrb, and Klf4 mRNAs) involved in maintenance of pluripotency of mouse ESCs and Thoc5 in maintenance of hematopoiesis and HSP70 mRNA export (Katahira, Inoue, Hurt, & Yoneda, 2009; Mancini et al., 2010) . Mouse modeling shows that both Thoc1 and Thoc5 knockouts are embryonic lethal (Mancini et al., 2010; Wang, Chang, Li, Zhang, & Goodrich, 2006) . However, Thoc1 and Thoc5 expression in a range of developing and adult tissues may indicate that the two genes have a more essential role in early embryonic development compared to less stringent requirement during later stages of embryonic or adult development (Mancini et al., 2010; Wang et al., 2006) ; a functional pattern most likely followed by the THOC2 gene. Essentiality of THOC2 gene indicates that THOC2 knockout will also be lethal. However, reduced levels or perturbed functionality can lead to a range of NDD phenotypes as observed for a cohort of THOC2 variants identified by us. It is now well established that development of brain depends on tightly regulated and complex sequence of events involving neuronal and glial cell proliferation, migration, and maturation (Chiurazzi & Pirozzi, 2016) . Therefore, it is not surprising that our THOC2 variant data and published work (Dickinson et al., 2016) provides strong evidence that even subtle alterations to the canonical molecular pathways such as mRNA export, otherwise essential for cellular life, can be tolerated but at a cost of a NDD.
In summary, we present detailed clinical data on seven individuals with THOC2-associated ID caused by both missense and splice variants that meet ACMG criteria for (likely) pathogenicity. They have a core phenotype of ID, and common findings of behavioural disorders, infantile hypotonia, gait disturbance and growth impairment, similar to the affected males with THOC2-associated ID we previously reported (Kumar et al., 2015) . Other than the affected female with a de novo missense variant, heterozygote carrier females are typically unaffected. We also present data on five individuals with four previously unreported rare missense variants that show clinical overlap with our core group, but where convincing evidence for causality is still required. The significance of these variants may be clarified as additional individuals with THOC2 variants are reported.
We have also "adopted" THOC2 on the Human Disease Gene (HDG)
Website Series (https://humandiseasegenes.nl/thoc2) in an effort to continue to explore the phenotypic-genotypic spectrum for THOC2-related ID.
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